Applying a single molecular probe to monitor biomarkers in multiple, complementary imaging modalities is highly desirable to ascertain detection and to avoid the complexity associated with the use of agents of different chemical entities. We demonstrate the versatility of lanthanide complexes with respect to their potential for enzymatic detection in NIR luminescence, CEST and T1 MR imaging, controlled by the nature of the Ln3+ ion.
A lire aussi
A new anticancer therapeutic strategy targeting the protein kinases LIMKs via new innovative chemical compounds
29 October 2024
par Isabelle Frapart
2024, November 15 - Seminar of Gyula TIRCSO
25 October 2024
par Isabelle Frapart
2024, November 8 - Seminar of Sophia MISSOURRY
25 October 2024
par Isabelle Frapart